Date:5/13/2010

17,554) (58,311) - depreciation of property, plant and equipment and amortization of licenses and permits 891,007 483,670 - deferred government grant recognized in income (65,830) (51,316) - accounts receivable 1,829,731 (2,462,999) - inventories (3,771,749) (2,331,763) - income tax payable (2,628,408) (885,252) - prepaid expenses and deposits (335,770) 30,904 - long term payable, deferred revenue and advances from customers (234,054) -- - accounts payable and accrued liabilities (6,100,581) (2,771,775) Net cash used in operating activities (10,146,421) (6,832,231) Cash flows from (used in) financing activities - Loan proceeds 8,265,031 -- - Proceeds from issuance of common stock net of share issuance costs 61,867,706 -- - Repurchase of common shares -- (319,643) - Loan to non-controlling shareholder of Sinovac Beijing (6,572,159) (1,460,600) - Government grant received 46,811 -- Net cash provided by (used in) financing activities 63,607,389 (1,780,243) Cash flows used in investing activities - Restricted cash 57,961 -- - Proceeds from disposal of equipment 189,876 -- - Proceeds from redemption of short - term investments 7,314,187 -- - Purchase of short-term investments (8,338,173) -- - Pr
'/>"/>

SOURCE Sinovac Biotech Ltd. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related biology technology :

1. Sinovac to Host Conference Call to Report First Quarter 2010 Financial Results
2. Sinovac Announces Upsizing and Pricing of Common Share Offering
3. Sinovac Files Clinical Trial Application with SFDA for Vaccine Against Hand, Foot, and Mouth Disease
4. Sinovacs CEO Weidong Yin Presented with Annual Innovation Award by China Central Television
5. Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities
6. Sinovac Reports Unaudited Third Quarter 2009 Financial Results
7. Sinovac Obtains Third H1N1 Vaccine Order from Chinese Central Government
8. Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong
9. Sinovac to Present at 2009 UBS Global Life Sciences Conference
10. Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine
11. Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government